Michael H. Allen, M. D.
Patients (Abbott Laboratories M95-305). Principal Investigator.
Comparison of the Safety and Efficacy of Depakote and Zyprexa in the Treatment of Bipolar Disorder (Abbott M99-045). Principal Investigator.
Safety and Efficacy of Depakote as Combination Therapy in the Treatment of Psychosis Associated with Schizophrenia (Abbott Laboratories M99-010). Principal Investigator.
Risperidone Depot (Microspheres) vs Placebo in the Treatment of Subjects with Schizophrenia or Schizoaffective Disorder (Janssen RIS-USA-121). Principal Investigator.
Systematic Treatment Enhancement Program for Bipolar Disorder (NIMH-DS-0098) Principal Investigator.
A Controlled Trial of the Efficacy of Rapid Initial Dose Escalation of Olanzapine to Treat Acute Behavioral Agitation in Schizophrenia and Bipolar I Disorder (Lilly F1D-US-HGIY). Principal Investigator.
Rocky Mountain Clinical Trial Node (NIDA DA-99-004). Scientific Advisory Committee.
Randomized Trial of Oral Risperidone Versus Intramuscular Haloperidol in the Emergency Treatment of Acute Psychosis (Janssen RIS-USA-235). Consultant.
Efficacy and Safety of Flexible Doses of Risperidone vs. Placebo or Divalproex Sodium in the Treatment of Manic or Mixed Episodes… (Janssen RIS-USA-240, 241). Investigator.
Multicenter Randomized, Double-Blind Study of Flexible Doses of Aripiprazole versus Perphenazine in the Treatment of Patients with Treatment-Resistant Schizophrenia (Bristol Meyers Squibb CN 138-032). Investigator.
Randomized, Double-Blind Study of the Safety and Efficacy of Depakote ER plus Atypical Antipsychotic vs. Atypical Antipsychotic Alone in the Treatment of Schizophrenia. (Abbott Laboratories M02-547). Subinvestigator.
A Double Blind Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia (Lilly F1D-MC-HGJZ). Investigator.
An Open-Label Study of Intramuscular Olanzapine Depot in Patients with Schizophrenia or Schizoaffective Disorder (Lilly F1D-MC-HGKB). Investigator.
A multicenter, open-label, flexible-dose, parallel-group evaluation of the cataractogenic potential of quetiapine fumarate (SEROQUEL) and risperidone (RISPERDAL) in the long-term treatment of subjects with schizophrenia or schizoaffective disorder (AstraZeneca CLEARS 5077IL/0089). Subinvestigator.
A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients with Bipolar I Disorder. Bristol-Meyers Squibb CN138125. Subinvestigator.
Selected Expert Testimony
Custody. Edwin C. Rendall v. Carol W. Rendall. Circuit Court, Montgomery County,